메뉴 건너뛰기




Volumn 75, Issue 2, 1995, Pages 495-502

Improved survival of patients with melanoma with an antibody response to immunization to a polyvalent melanoma vaccine

Author keywords

antibody; cancer; immunotherapy; melanoma; survival; vaccine

Indexed keywords

MELANOMA VACCINE;

EID: 0028870490     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19950115)75:2<495::AID-CNCR2820750212>3.0.CO;2-S     Document Type: Article
Times cited : (64)

References (23)
  • 3
    • 0017834619 scopus 로고
    • Antibody response and tumor growth in syngeneic mice immunized to partially purified B16 melanoma associated antigens
    • (1978) J Immunol , vol.120 , pp. 96-101
    • Bystryn, J‐C1
  • 6
    • 0023552308 scopus 로고
    • Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma: treatment of stage II melanoma with viral lysates
    • (1987) Cancer Immunol Immunother , vol.25 , pp. 257-265
    • Hersey, P1    Edwards, A2    Coates, A3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.